2015
DOI: 10.3109/02656736.2015.1006690
|View full text |Cite
|
Sign up to set email alerts
|

Focused ultrasound for treatment of bone tumours

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
32
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 42 publications
(35 citation statements)
references
References 69 publications
3
32
0
Order By: Relevance
“…When targeting the MB nerve using an extracorporeal FUS system, the cortical bone of the vertebral body and the transverse and superior articular processes are likely to serve as natural absorbers of ultrasound energy, preventing a significant portion of the far-field ultrasound beam from reaching the critical neural structures. Nonetheless, when using the clinical FUS system, which operates at a lower frequency of 1.35 MHz, an obvious concern is inadvertent damage of the spinal cord or exiting nerve root structures, which typically precludes the clinical application of MRgFUS in patients with spinal tumors [26]. In this work, the in vivo acute study demonstrated that the selected acoustic parameters and the targeting strategy did not damage the spinal cord and the lumbar nerve roots.…”
Section: Discussionmentioning
confidence: 81%
“…When targeting the MB nerve using an extracorporeal FUS system, the cortical bone of the vertebral body and the transverse and superior articular processes are likely to serve as natural absorbers of ultrasound energy, preventing a significant portion of the far-field ultrasound beam from reaching the critical neural structures. Nonetheless, when using the clinical FUS system, which operates at a lower frequency of 1.35 MHz, an obvious concern is inadvertent damage of the spinal cord or exiting nerve root structures, which typically precludes the clinical application of MRgFUS in patients with spinal tumors [26]. In this work, the in vivo acute study demonstrated that the selected acoustic parameters and the targeting strategy did not damage the spinal cord and the lumbar nerve roots.…”
Section: Discussionmentioning
confidence: 81%
“…74 A recent article reviewed the clinical applications of FUS and provided a comprehensive overview of HIFU employment on bone tumours, describing background, results of clinical studies and suggesting future directions. 75 MRgFUS has been first proposed with a potential in pain palliation of bone metastases, for its good results in patients non-responding to radiotherapy while applying acoustic energy on the bone surface resulting in bone cortex heating, and indirectly ablating the adjacent periosteum-the most innervated component of mature bone tissue, and tumour tissue, and a major source of pain. 11,76 The bone is a common site for metastasis.…”
Section: Mrgfus Target and Applications In Musculoskeletal Pathologymentioning
confidence: 99%
“…Major complications were reported in the ranges of 0%, 0-28% and 0-4% for primary benign, malignant and metastatic tumours, respectively. 75 Degenerative diseases Osteoarthritis (OA) is a common, disabling and costly disease. The predominant symptom is pain.…”
Section: Mrgfus Target and Applications In Musculoskeletal Pathologymentioning
confidence: 99%
See 1 more Smart Citation
“…This is being used to cause neurolysis to palliate the pain caused by bone metastases [13,14]. More than 1000 such patients have now been treated [15].…”
Section: High Intensity Focused Ultrasoundmentioning
confidence: 99%